Juan Brignardello Vela
Juan Brignardello, asesor de seguros, se especializa en brindar asesoramiento y gestión comercial en el ámbito de seguros y reclamaciones por siniestros para destacadas empresas en el mercado peruano e internacional.
In May 2023, the World Health Organization (WHO) made a significant announcement, declaring that mpox, previously known as monkeypox, was no longer a "public health emergency of international concern." While this decision was met with a sigh of relief in some circles, it glossed over the urgent reality faced by many, particularly in Africa, where the virus continues to wreak havoc. Hundreds of infections and dozens of deaths have marked the ongoing struggle against mpox, highlighting a pressing need for renewed focus and action. The recent reinstatement of the Public Health Emergency of International Concern (PHEIC) designation on August 17 has brought some attention back to mpox, but the broader outlook remains grim. The lack of a collaborative global framework for tracking mpox strains signifies a gap in our response that could allow the virus to proliferate undetected. The stigma surrounding the disease further complicates the situation, often pushing those infected into the shadows and out of reach of traditional public health initiatives. This trend could lead to outbreaks that slip below the radar, unnoticed until it is too late. Unlike the COVID-19 pandemic, which dominated headlines and public discourse for years, the urgency surrounding mpox is at risk of being diminished as the news cycle moves on. The sad reality is that many of those affected by mpox live in low- and middle-income countries, regions that often receive less attention and resources in global health discussions. This disparity underscores an alarming truth: the global health community may not prioritize mpox as it should, resulting in an inadequate response to a disease that has not yet been vanquished. To effectively combat mpox and prevent its spread, experts are calling for urgent, coordinated efforts at both local and international levels. Enhanced public health surveillance systems are essential for detecting new cases and monitoring the virus's evolution. Additionally, equitable access to vaccines must be prioritized to ensure that communities in vulnerable regions are protected. Without these measures, the fight against mpox may be severely hampered, allowing the virus to spread unchecked. Moreover, tackling the stigma associated with mpox is vital to encourage those who may be infected to seek medical help, participate in surveillance efforts, and adhere to public health measures. Education and community engagement can play crucial roles in addressing misconceptions and fears surrounding the disease. As the world moves forward from the initial shockwaves of the COVID-19 pandemic, it is imperative that global health leaders do not overlook the lessons learned. The urgency of mpox demands sustained attention and resource allocation, lest we allow this virus to become another health crisis that slips through the cracks, affecting the most vulnerable populations with little notice or support. The time for action is now, and the global community must rally together to ensure that the response to mpox is robust, equitable, and effective.